Semisynthesis of an Anticancer DPAGT1 Inhibitor from a Muraymycin Biosynthetic Intermediate-Reference-Cited by-同舟云学术

Semisynthesis of an Anticancer DPAGT1 Inhibitor from a Muraymycin Biosynthetic Intermediate

Published:2019-01-30 Issue:4 Volume:21 Page:876-879
ISSN:1523-7060
Container-title:Organic Letters
language:en
Short-container-title:Org. Lett.

Author:

Mitachi Katsuhiko¹,Kurosu Shou M.¹,Eslamimehr Shakiba¹,Lemieux Maddie R.¹,Ishizaki Yoshimasa²,Clemons William M.³,Kurosu Michio¹^ORCID

Affiliation:

1. Department of Pharmaceutical Sciences, College of Pharmacy, University of Tennessee Health Science Center, 881 Madison Avenue, Memphis, Tennessee 38163, United States

2. Laboratory of Microbiology, Institute of Microbial Chemistry (BIKAKEN), 3-14-23, Kamiosaki, Shinagawa-ku, Tokyo 141-0021, Japan

3. Division of Chemistry and Chemical Engineering, California Institute of Technology, 1200 E. California Boulevard, Pasadena, California 91125, United States

Funder

U.S. Department of Health and Human Services

Health Science Center, University of Tennessee

Publisher

American Chemical Society (ACS)

Subject

Organic Chemistry,Physical and Theoretical Chemistry,Biochemistry

Link

https://pubs.acs.org/doi/pdf/10.1021/acs.orglett.8b03716

Reference26 articles.

1. Inhibition of N-Glycosylation towards Novel Anti-Cancer Chemotherapeutics

2. Stereocontrolled Total Synthesis of Muraymycin D1 Having a Dual Mode of Action against Mycobacterium tuberculosis